CSCO Guidelines

CSCO guidelines for colorectal cancer version 2024: Updates and discussions
Liubo Chen, Hanguang Hu, Ying Yuan, Shanshan Weng

Consensus and Expert Recommendation

Evidence-based expert consensus on clinical management of safety of Bruton’s tyrosine kinase inhibitors (2024)
Zaiwei Song, Dan Jiang, Lingling Yu, Yixuan Chen, Daobin Zhou, Yue Li, Depei Wu, Lingli Zhang, Liyan Miao, Jun Ma, Jun Zhu, Hongmei Jing, Rongsheng Zhao, on behalf of the Steering Committee, the Consensus Panel and the Evidence Synthesis Group; Evidence-based Pharmacy Professional Committee of Chinese Pharmaceutical Association (CPA), Hospital Pharmacy Professional Committee of Chinese Pharmaceutical Association (CPA), Division of Therapeutic Drug Monitoring of Chinese Pharmacological Society (CPS), Expert Committee on Lymphoma of Chinese Society of Clinical Oncology (CSCO), Expert Committee on Leukemia of Chinese Society of Clinical Oncology (CSCO), Society of Integrative Cardio-Oncology of China Anti-Cancer Association (CACA), Chinese Society of Hematology of Chinese Medical Association (CMA), Hospital Pharmacy Professional Committee of Cross-Straits Medicine Exchange Association (SMEA)

Original Article

Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/mismatch repair-deficient solid tumors
Jian Li, Ye Xu, Aimin Zang, Yunong Gao, Quanli Gao, Yanqiao Zhang, Dong Wang, Jianming Xu, Ying Yuan, Haiping Jiang, Jieer Ying, Chunmei Shi, Yanhong Deng, Jing Wang, Tianshu Liu, Yi Huang, Xiaoping Qian, Yueyin Pan, Ying Cheng, Sheng Hu, Jin Wang, Mengyue Shi, Ke Wang, Han Hu, Lin Shen
Effectiveness and safety of combined nimotuzumab and S-1 chemotherapy with concurrent radiotherapy for locally advanced esophageal cancer in malnourished and elderly patients: A prospective phase II study
Guojie Feng, Jiao Li, Nuo Yu, Ziyu Zheng, Xiongtao Yang, Lei Deng, Tao Zhang, Wenqing Wang, Wenyang Liu, Jianyang Wang, Qinfu Feng, Jima Lyu, Zefen Xiao, Zongmei Zhou, Nan Bi, Jianjun Qin, Xin Wang
Clinical and molecular significance of homologous recombination deficiency positive non-small cell lung cancer in Chinese population: An integrated genomic and transcriptional analysis
Yifei Wang, Yidan Ma, Lei He, Jun Du, Xiaoguang Li, Peng Jiao, Xiaonan Wu, Xiaomao Xu, Wei Zhou, Li Yang, Jing Di, Changbin Zhu, Liming Xu, Tianlin Sun, Lin Li, Dongge Liu, Zheng Wang
Nucleotide excision repair gene polymorphisms and hepatoblastoma susceptibility in Eastern Chinese children: A five-center case-control study
Huimin Yin, Xianqiang Wang, Shouhua Zhang, Shaohua He, Wenli Zhang, Hongting Lu, Yizhen Wang, Jing He, Chunlei Zhou

Review Article

Mechanisms of resistance to trastuzumab in HER2-positive gastric cancer
Zhifei Li, Huan Zhao, Huihui Hu, Haili Shang, Yongjing Ren, Wenhui Qiu, Hao Su, Huifang Lyu, Xiaobing Chen
Unlocking epigenetics for precision treatment of Ewing’s sarcoma
Zhehao Fan, Shuangshuang Dong, Ning Wang, Muhammad Babar Khawar, Jingcheng Wang, Haibo Sun

Brief Communication

Unraveling links between aging, circadian rhythm and cancer: Insights from evidence-based analysis
Dechao Feng, Yuhan Xiao, Jie Wang, Ruicheng Wu, Zhouting Tuo, Koo Han Yoo, Wuran Wei, Dilinaer Wusiman, Zhipeng Wang, Dengxiong Li, Yubo Yang, William C. Cho, Mang Ke

NHCPRC Guidelines

National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version)
National Health Commission of the People’s Republic of China; Society of Oncology, Chinese Medical Association
National guidelines for diagnosis and treatment of malignant lymphoma 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of esophageal carcinoma 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of melanoma 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of lung cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of colorectal cancer 2020 in China (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of melanoma 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of malignant lymphoma 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of breast cancer 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of pancreatic cancer 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of cervical cancer 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of renal cell carcinoma 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of urothelial carcinoma of bladder 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of prostate cancer 2018 (English version)
National Health Commission of the People’s Republic of China

CSCO Guidelines

CSCO guidelines for colorectal cancer version 2023: Updates and insights
Mi Mi, Shanshan Weng, Ziheng Xu, Hanguang Hu, Yi Wang, Ying Yuan
CSCO guidelines for colorectal cancer version 2022: Updates and discussions
Zhijun Yuan, Shanshan Weng, Chenyang Ye, Hanguang Hu, Suzhan Zhang, Ying Yuan
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)
Jun Zhu, Jun Ma, Union for China Lymphoma Investigators of Chinese Society of Clinical Oncology
Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020
Caixia Dong, Yuwei Ding, Shanshan Weng, Guichao Li, Yanqing Huang, Hanguang Hu, Zhen Zhang, Suzhan Zhang, Ying Yuan
Updates in version 2020 of CSCO guidelines for colorectal cancer from version 2019
Shanshan Weng, Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang
Updates in version 2019 of CSCO guidelines for colorectal cancer from version 2018
Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer 2018 (English version)
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer working group
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 (English version)
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer working group
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version)
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer working group

Guidelines

Management guidelines for preventing exposure to antineoplastics
Wei Liu, Ziyang Wu, Tong Sun, Shuyao Liang, Jun Zhu, Suodi Zhai, Division of Therapeutic Drug Monitoring of Chinese Pharmacological Society, Hospital Pharmacy Professional Committee of Chinese Pharmaceutical Association, Oncology Society of Chinese Medical Association, Nursing Branch of China International Exchange and Promotive Association for Medical and Healthcare, Division of Drug-induced Diseases of Chinese Pharmacology Society